TPST
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
时间：2024-12-07 05:30:00 市场： 美股 综合
Tempest Therapeutics Q3 EPS USD -0.41 VS. Ibes Estimate USD -0.36
时间：2024-11-13 05:21:02 市场： 美股 综合
Tempest Therapeutics Shares up 29% at $1.74 Premarket After Agreement to Test Its Liver Cancer Drug With Roche's Therapy in Pivotal Study
时间：2024-10-10 19:46:27 市场： 综合 美股
Tempest Further Strengthens Leadership Team With Appointment of Sheldon Mullins as Vice President, Regulatory Affairs
时间：2024-09-18 20:00:04 市场： 美股 综合